Evidence map›Paper›PMID 37738914›Full record

ArticleJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2023

Clinical implications of Peri-hematomal edema microperfusion fraction in intracerebral hemorrhage intravoxel incoherent motion imaging - A pilot study.

Gaby Abou Karam, Hishan Tharmaseelan, Mariam S Aboian, Ajay Malhotra, Emily J Gilmore, Guido J Falcone, Adam de Havenon, Kevin N Sheth, Seyedmehdi Payabvash

Open access · bronzeAbstract read
In one paragraph

Article in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Gaby Abou KaramSection of Neuroradiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine. 333 Cedar St, New Haven, CT 06510, USA.
Hishan TharmaseelanSection of Neuroradiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine. 333 Cedar St, New Haven, CT 06510, USA.
Mariam S AboianSection of Neuroradiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine. 333 Cedar St, New Haven, CT 06510, USA.
Ajay MalhotraSection of Neuroradiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine. 333 Cedar St, New Haven, CT 06510, USA.
Emily J GilmoreDivision of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06510, USA; Center for Brain and Mind Health, Yale School of Medicine, 333 Cedar St, New Haven, CT 06510, USA.
Guido J FalconeDivision of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06510, USA; Center for Brain and Mind Health, Yale School of Medicine, 333 Cedar St, New Haven, CT 06510, USA.
Adam de HavenonCenter for Brain and Mind Health, Yale School of Medicine, 333 Cedar St, New Haven, CT 06510, USA; Division of Vascular Neurology, Department of Neurology, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06510, USA.
Kevin N ShethDivision of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06510, USA; Center for Brain and Mind Health, Yale School of Medicine, 333 Cedar St, New Haven, CT 06510, USA.
Seyedmehdi PayabvashSection of Neuroradiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine. 333 Cedar St, New Haven, CT 06510, USA; Center for Brain and Mind Health, Yale School of Medicine, 333 Cedar St, New Haven, CT 06510, USA. Electronic address: sam.payabvash@yale.edu.
Yale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Albert C Shaw · 2002 to 2026
$37.9M
Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)U01NS106513 · NINDS · YALE UNIVERSITY · PI Hooman Kamel, Kevin Navin Sheth · 2019 to 2026
$20.6M
Social networks and risk of delayed arrival to the hospital during strokeR01MD016178 · NIMHD · BRIGHAM AND WOMEN'S HOSPITAL · PI Amar Dhand, Kevin Navin Sheth · 2022 to 2026
$3.7M
The Recovery in Stroke Using PAP (RISE UP) StudyR01NR018335 · NINR · YALE UNIVERSITY · PI REDEKER, NANCY S, SHETH, KEVIN NAVIN · 2019 to 2023
$3.4M
ELECTRO-BOOST: Electroencephalography for cerebral trauma recovery and oxygenationR01NS117904 · NINDS · YALE UNIVERSITY · PI DING, KAN, GILMORE, EMILY · 2020 to 2025
$3.2M
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)U24NS107215 · NINDS · YALE UNIVERSITY · PI MARK Jay ALBERTS, Karen L Furie · 2018 to 2026
$3.0M
Blood Pressure Variability and Ischemic Stroke Outcome (BP-VISO)R01NS130189 · NINDS · YALE UNIVERSITY · PI Adam H. de Havenon · 2023 to 2026
$2.0M
Improved glyburide therapy via acid- triggered release functional nanoparticles and therapeutic imagingR01NS110721 · NINDS · YALE UNIVERSITY · PI SHETH, KEVIN NAVIN, ZHOU, JIANGBING · 2019 to 2023
$1.9M
Yale-METRO Metropolitan Emergency Trial netwoRK to advance patient OutcomesU24NS129500 · NINDS · YALE UNIVERSITY · PI Gail D'Onofrio, Kevin Navin Sheth · 2023 to 2026
$1.7M
Yale Clinical Site: Investigations For Improved Neurological Treatments at Yale (INFINITY)U24NS107136 · NINDS · YALE UNIVERSITY · PI SHETH, KEVIN NAVIN, SPUDICH, SERENA S · 2018 to 2022
$1.7M
Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRIK23NS105924 · NINDS · YALE UNIVERSITY · PI DE HAVENON, ADAM H. · 2019 to 2023
$988k
Doris Duke Charitable Foundation 2020097NCATS NIH HHS UL1 TR001863NIA NIH HHS K76 AG059992NIA NIH HHS P30 AG021342NIMHD NIH HHS R01 MD016178NINDS NIH HHS K23 NS105924NINDS NIH HHS K23 NS118056NINDS NIH HHS R01 NS110721NINDS NIH HHS R01 NS117904NINDS NIH HHS R01 NS130189NINDS NIH HHS R03 NS112859NINDS NIH HHS U01 NS106513NINDS NIH HHS U24 NS107136NINDS NIH HHS U24 NS107215NINDS NIH HHS U24 NS129500NINR NIH HHS R01 NR018335
6 · The paper itself

Abstract

background and purposePerihematomal edema (PHE) represents the secondary brain injury after intracerebral hemorrhage (ICH). However, neurobiological characteristics of post-ICH parenchymal injury other than PHE volume have not been fully characterized. Using intravoxel incoherent motion imaging (IVIM), we explored the clinical correlates of PHE diffusion and (micro)perfusion metrics in subacute ICH. MATERIALS AND

methodsIn 41 consecutive patients scanned 1-to-7 days after supratentorial ICH, we determined the mean diffusion (D), pseudo-diffusion (D*), and perfusion fraction (F) within manually segmented PHE. Using univariable and multivariable statistics, we evaluated the relationship of these IVIM metrics with 3-month outcome based on the modified Rankin Scale (mRS).

resultsIn our cohort, the average (± standard deviation) age of patients was 68.6±15.6 years, median (interquartile) baseline National Institute of Health Stroke Scale (NIHSS) was 7 (3-13), 11 (27 %) patients had poor outcomes (mRS>3), and 4 (10 %) deceased during the follow-up period. In univariable analyses, admission NIHSS (p < 0.001), ICH volume (p = 0.019), ICH+PHE volume (p = 0.016), and average F of the PHE (p = 0.005) had significant correlation with 3-month mRS. In multivariable model, the admission NIHSS (p = 0.006) and average F perfusion fraction of the PHE (p = 0.003) were predictors of 3-month mRS.

conclusionThe IVIM perfusion fraction (F) maps represent the blood flow within microvasculature. Our pilot study shows that higher PHE microperfusion in subacute ICH is associated with worse outcomes. Once validated in larger cohorts, IVIM metrics may provide insight into neurobiology of post-ICH secondary brain injury and identify at-risk patients who may benefit from neuroprotective therapy.

Indexed as

Brain EdemaBrain InjuriesBrain NeoplasmsAgedAged, 80 and overCerebral HemorrhageDiffusion Magnetic Resonance ImagingEdemaHematomaHumansMiddle AgedPilot ProjectsHemorrhagic strokeIntravoxel incoherent motion imagingPerfusion fractionPeri-hematoma edema

Identifiers

PMID37738914
PMCPMC10591892
OpenAlexW4386906282

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.